Expression of arylamine N-acetyltransferases in pre-term placentas and in human pre-implantation embryos

Human Molecular Genetics

Volumn 9, Issue 7, 2000, Pages 1101-1107

  Smelt, V A ^c   Upton, A ^c   Adjaye, J ^a   Payton, M A ^c   Boukouvala, S ^c   Johnson, N ^c   Mardon, H J ^b   Sim, E ^c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARYLAMINE ACETYLTRANSFERASE; ISOENZYME;

ARTICLE; BLASTOCYST; CONTROLLED STUDY; EMBRYO; FEMALE; HUMAN; HUMAN TISSUE; PLACENTA; PREIMPLANTATION EMBRYO; PREMATURITY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

MURINAE;

EID: 0034639999     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/9.7.1101     Document Type: Article

References (57)

1. Luke, B. (1994) Nutritional influences on fetal growth. Clin. Obstet. Gynecol., 3, 538-549.
2. Page, E.W. (1957) Transfer of materials across the human placenta. Am. J. Obstet. Gynaecol., 74, 705-718.
3. Bourget, P., Roulot, C. and Fernandez, H. (1995) Models for placental transfer studies of drugs. Clin. Pharmacokinet. Concepts, 28, 161-180.
4. Simone, C., Derewlany, L.O. and Koren, G. (1994) Drug transfer across the placenta. Considerations in treatment and research. Clin. Perinatol., 21, 463-481.
5. Weber, W.W. and Hein, D.W. (1985) N-acelylation pharmacogenetics. Pharmacol. Rev., 37, 25-79.
6. Hein, D.W., Doll, M.A., Rustan, T.D., Gray, K., Feng, Y., Ferguson, R.J. and Grant, D.M. (1993) Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferases. Carcinogenesis, 14, 1633-1638.
7. Windmill, K.F., McKinnon, R.A., Zhu, X., Gaedigk, A., Grant, D.M. and McManus, M.E. (1997) The role of xenobiotic metabolizing enzymes in arylamine toxicity and carcinogenesis: functional and localization studies. Mutat. Res., 376, 153-160.
8. Vineis, P., Caporaso, N., Tannenbaum, S.R., Skipper, P.L., Glogowski, J., Bartsch, H., Coda, M., Talaska, G. and Kadlubar, F. (1990) Acetylation phenotype, carcinogen-hemoglobin adducts, and cigarette smoking. Cancer Res., 50, 3002-3004.
9. Grant, D.M., Josephy, P.D., Lord, H.L. and Morrison, L.D. (1992) Salmonella typhimurium strains expressing human arylamine N-acetyltransferases: metabolism and mutagenic activation of aromatic amines. Cancer Res., 52, 3961-3964
10. Jenne, J.W. (1965) Partial purification and properties of the isoniazid transacetylase in human liver. Its relationship to the acetylation of paraaminosalicyclic acid in man. J. Clin. Invest., 44, 1992-2002.
11. Ilett, K.F., Ingram, D.M., Carpenter, D.S., Teitel, C.H., Lang, N.P., Kadlubar, F.F. and Minchin, R.F. (1994) Expression of monomorphic and polymorphic N-acetyltransferases in human colon. Biochem. Pharmacol., 47, 914-917
12. Hickman, D., Pope, J., Patil, S.D., Fakis, G., Smelt, V., Stanley, L.A., Payton, M., Unadkat, J.D. and Sim, E. (1998) Expression of arylamine N-acetyltransferase in human intestine. Gut, 42, 402-409.
13. Ohsako, S. and Deguchi, T. (1990) Cloning and expression of cDNAs for polymorphic and monomorphic arylamine N-acetyltransferases from human liver. J. Biol. Chem., 265, 4630-4634.
14. Badawi, A.F., Hirvonen, A., Bell, D.A., Lang, N.P. and Kadlubar, F.F. (1995) Role of aromatic amine acetyltransferases, NAT1 and NAT2 in carcinogen-DNA adduct formation in the human urinary baldder. Cancer Res., 55, 5230-5237.
15. Cribb, A.E., Grant, D.M., Miller, M.A. and Spielberg, S.P. (1991) Expression of monomorphic arylamine N-acetyltransferase (NAT) in human leukocytes. J. Pharmacol. Exp. Ther., 259, 1241-1246.
16. Ward, A., Hickman, D., Gordon, J.W. and Sim, E. (1992) Arylamine N-acetyltransferase in human red blood cells. Biochem. Pharmacol., 44, 1099-1104.
17. Blum, M., Derrierre, A., Grant, D.M., Heim, M. and Meyer, U.A. (1991) Molecular mechanism of slow acetylation of drugs and carcinogens in humans. Proc. Natl Acad. Sci. USA, 88, 5237-5241.
18. Vatsis, K.P. and Weber, W.W. (1993) Structural heterogeneity of Caucasian N-acetyltransferase at the NAT1 gene locus. Arch. Biochem. Biophys., 301, 71-76.
19. Vatsis, K.P., Weber, W.W., Bell, D.A., Dupret, J.-M., Price-Evans, D.A., Grant, D.M., Hein, D.W., Lin, H.J., Meyer, U.A., Relling, M.V., Sim, E., Suzuki, T. and Yamazoe, Y. (1995) Nomenclature for N-acetyltransferases. Pharmacogenetics, 5, 1-17
20. Hickman, D. and Sim, E. (1991) N-acetyltransferase polymorphism. Comparison of phenotype and genotype in humans. Biochem. Pharmacol., 42, 1007-1014.
21. http://www.louisville.edu/medschool/pharmacology/NAT.html
22. Grant, D.M., Hughes, N.C., Janezic, S.A., Goodfellow, G.H., Chen, H.J., Gaedigk, A., Yu, V.L. and Grewal, R. (1997) Human acetyltransferase polymorphisms. Mutat. Res., 376, 61-70.
23. Payton, M.A. and Sim, E. (1998) Genotyping human arylamine N-acetyltransferase type 1 (NAT1): the identification of two novel allelic variants. Biochem. Pharmacol., 55, 361-366.
24. Butcher, N.J., Ilett, K.F. and Minchin, R.F. (1998) Functional polymorphism of the human arylamine N-acetyltransferase type 1 gene caused by C190T and G560A mutations. Pharmacogenetics, 8, 67-72.
25. Blum, M., Grant, D.M., McBride, O.W., Heim, M. and Meyer, U.A. (1990) Human arylamine N-acetyltransferase genes: isolation, chromosomal localization, and functional expression. DNA Cell Biol., 9, 193-203.
26. Zenser, T.V., Lakshmi, V.M., Rustan, T.D., Doll, M.A., Deitz, A.C., Davis, B.B. and Hein, D.W. (1996) Human N-acetylation of benzidine: role of NAT1 and NAT2. Cancer Res., 56, 3941-3947.
27. Okumura, K., Kita, T., Chikazawa, S., Komada, F., Iwakawa, S. and Tanigawara, Y. (1997) Genotyping of N-acetylation polymorphism and correlation with procainamide metabolism. Clin. Pharmacol. Ther., 61, 509-517.
28. Minchin, R.F. (1995) Acetylation of p-aminobenzoylglutamate, a folic acid catabolite, by recombinant human arylamine N-acetyltransferase and U937 cells. Biochem. J., 307, 1-3.
29. Ward, A., Summers, M. and Sim, E. (1995) Purification of recombinant human N-acetyltransferase type 1 (NAT1) expressed in E.coli and characterization of its potential role in folate metabolism. Biochem. Pharmacol., 49, 1759-1767.
30. Derewlany, L.O., Knie, B. and Koren, G. (1994) Arylamine N-acetyltransferase activity of the human placenta. J. Pharmacol. Exp. Ther., 269, 756-760.
31. Kelly, S.L. and Sim, E. (1991) Expression of N-acetyl transferase in a human monocytic cell-line, U937. Hum. Exp. Toxicol., 10, 33-38.
32. Scott, J.M., McPartlin, J., Molloy, A., McNulty, H., Halligan, A., Darling, M. and Weir, D.G. (1993) Folate metabolism in pregnancy. Adv. Exp. Biol., 338, 727-732.
33. McPartlin, J., Courtney, G., McNulty, H., Weir, D.G. and Scott, J.M. (1992) The quantitative analysis of endogenous folate catabolism in human urine. Anal. Biochem., 206, 256-261.
34. Geoghegan, F.L., McPartlin, J.M., Weir, D.G. and Scott, J.M. (1997) paraacetamidobenzoylglutamate is a suitable indicator of folate catabolism in rats. J. Nutr., 125, 2563-2570.
35. MRC Vitamin Study Research Group (1991) Prevention of neural tube defects: results of the MRC vitamin study. Lancet. 338, 132-137.
36. Carter, M., Ulrich, S., Oofujl, Y., Williams, D.A. and Ross, M.E. (1999) Crooked tail (Cd) models human folate-responsive neural tube defects. Hum. Mol. Genet., 8, 2199-2204.
37. Leclerc, D., Campeau, E., Goyette, P., Adjalla, C.E., Christensen, B, Ross, M., Eydoux, P., Rosenblatt, D.S., Rozen, R. and Gravel, R.A. (1996) Human methionine synthase: cDNA cloning and identification of mutations in patients of the cblG complementatiuon group of folate/cobalamin disorders. Hum. Mol. Genet., 5, 1867-1874.
38. Wilson, A., Leclerc, D., Rosenblatt, D.S. and Gravel, R.A. (1999) Molecular basis for methionine synthase reductase deficiency in patients belonging to the cblE complementation group of disorders of folate/ cobalamin metabolism. Hum. Mol. Genet., 8, 2009-2016.
39. Sebastio, G., Sperandeo, M.P., Panico, M., de Franchis, R., Kraus, J.P. and Andria, G. (1995) The molecular basis of homocysteinuria due to cystathionine beta synthase deficiency in Italian families and report of four novel mutations. Am. J. Hum. Genet., 56, 1324-1333.
40. Bagley, P.J. and Selhub, J.A. (1998) A common mutation in the methylenetetrahydrofolate reductase gene is associated with an accumulation of formylated tetrahydrofolate in red blood cells. Proc. Natl Acad. Sci. USA, 95, 13217-13220.
41. Sheilds, D.C., Kirke, P.N., Mills, J.L., Ramsbottom, D., Molloy, A.M., Burke, H., Weir, D.G., Scott, J.M. and Whitehead, A.S. (1999) The 'thermolabile' variant of methylenetetrahydrofolate reductase and neural tube defects: an evaluation of genetic risk and the relative importance of the genotypes of the embryo and the mother. Am. J. Hum. Genet., 64, 1045-1055.
42. McQueen, C.A. and Weber, W.W. (1980) Characterization of human lymphocyte N-acetyltransferase and its relationship to the isoniazid acetylator polymorphism. Biochem. Genet., 18, 889-904.
43. Doll, M.A., Jiang, W., Deitz, A.C., Rustan, T.D. and Hein, D.W. (1997) Identification of a novel allele at the human NAT1 acetyltransferase locus. Biochem. Biophys. Res. Commun., 233, 584-591.
44. Smelt, V.A., Mardon, H.J. and Sim, E. (1998) Placental expression of arylamine N-acetyltransferases: evidence for linkage disequilibrium between NAT1*10 and NAT2*4 alleles of the two human arylamine N-acetyltransferase loci NAT1 and NAT2. Pharmacol. Toxicol., 83, 149-175.
45. Adjaye, J., Daniels, R. and Monk, M. (1998) cDNA libraries from single human preimplantation embryos. J. Assisted Reprod. Genet., 15, 344-348.
46. Hull, M.G.R., Joyce, D.N. and Turner, G. (1986) Obstetrics and Gynaecology. 2nd edn. Butterworth-Heinemann, Oxford, UK.
47. Pacifici, G.M., Bencicni, C. and Rane, A. (1986) Acetyltransferase in humans: development and tissue distribution. Pharmacology, 32, 283-291.
48. Pariente-Klayat, A., Pons, G., Rey, E., Richard, M.O., Dathis, P., Moran, C., Badoual, J. and Olive, G. (1991) Caffeine acetylator phenotyping during maturation in infants. Pediatr. Res., 29, 492-495.
49. Hakkola, J., Raunio, H., Purkunen, R., Pelkonen, O., Saarikoski, S., Cresteil, T. and Pasanen, M. (1996) Detection of cytochrome P450 gene expression in human placenta in first trimester of pregnancy. Biochem., Pharmacol., 52, 379-383.
50. Payton, M.A., Smelt, V.A., Upton, A. and Sim, E. (1999) Genotyping of the murine arylamine N-acetyltransferase type 2 (NAT2): a gene expressed in pre-implantation embryonic stem cells encoding an enzyme which acetylates the folate catabolite p-aminobenzoylglutamate. Biochem. Pharmacol., 58, 779-785.
51. Stanley, L.A., Copp, A.J, Pope, J., Rolls, S., Smelt, V., Perry, V.H. and Sim, E. (1998) Immunochemical detection of arylamine N-acetyltransferase during mouse embryonic development and in adult mouse brain. Teratology, 58, 174-182.
52. Mitchell, M.K., Futscher, B.W. and McQueen, CA. (1999) Developmental expression of N-acetyltransferases in C57BI/6 mice. Drug Metab. Disposition, 27, 261-264.
53. Karolyi, J., Erickson, R.P., Liu, S. and Killewald, L. (1990) Major effects on teratogen-induced facial clefting in mice determined by a single genetic region. Genetics, 126, 201-205.
54. Dilella, A.G. and Woo, S.L.C. (1987) Cloning large segments of genomic DNA using cosmid vectors. Methods Enzymol., 152, 199-212.
55. Risch, A., Smelt, V., Lane, D., Stanley, L., van der Slot, W., Ward, A. and Sim, E. (1996) Arylamine N-acetyltransferase in erylhrocytes of cystic fibrosis patients. Pharmacol. Toxicol., 78, 235-240.
56. Matas, N., Thygesen, P., Stacey, M., Risch, A. and Sim, E. (1997) Mapping AAC1, AAC2 and AACP, the genes for the carcinogen metabolising enzymes, N-acetyltransferases, on human chromosome 8p22, a region frequently deleted in tumours. Cytogenet. Cell Genet., 77, 290-295.
57. Gibbs, R.A., Nguygen, P.-N., McBride, L.J., Koepf, S.M. and Casey, C.T. (1989) Identification of mutations leading to the Lesch-Nyhan syndrome by automated direct DNA sequencing of in vitro amplified cDNA. Proc. Natl Acad. Sci. USA, 86, 1919-1923.